Epidemiology and Risk Factors of Hepatitis Delta Infection in Turkey
dc.contributor.author | Ayaz, C | |
dc.contributor.author | Koruk, ST | |
dc.contributor.author | Yalci, A | |
dc.contributor.author | Yamazhan, T | |
dc.contributor.author | Aygen, B | |
dc.contributor.author | Tosun, S | |
dc.contributor.author | Dal, T | |
dc.contributor.author | Celen, MK | |
dc.contributor.author | Tabak, F | |
dc.date.accessioned | 2024-07-18T12:07:33Z | |
dc.date.available | 2024-07-18T12:07:33Z | |
dc.description.abstract | This study is aimed to investigate the prevalence and risk factors of HDV co-infection in patients with chronic HBV infection in Turkey, where HBV infection is endemic. The date of this study was obtained from Turk-Hep-Net project. The project includes real-life cohort of HBV patients from 15 centers in Turkey and is supported by Viral Hepatitis Society. Of the 7366 HBsAg positive individuals tested for the presence of anti-HDV antibodies, 63,6 were male and 36.4 % were female. Of the 7366 HBsAg positif patients, 206 (2.8%) contained anti-HDV. Southeastern Anatolia Region of the country's anti-HDV positivity rate was found to be 4.5%. The risk factors in anti-HDV positivity patient were; male gender, long-term (>5 year) HBsAg positivity and living in Southeastern Anatolia. Our study revealed that recognizing the risk factors associated with HBV and HDV co-infection will be beneficial to control of these infections. | |
dc.identifier.issn | 0973-7510 | |
dc.identifier.uri | http://akademikarsiv.cbu.edu.tr:4000/handle/123456789/10499 | |
dc.language.iso | English | |
dc.publisher | DR M N KHAN | |
dc.subject | D VIRUS-INFECTION | |
dc.subject | BLOOD-DONORS | |
dc.subject | PREGNANT-WOMEN | |
dc.subject | PREVALENCE | |
dc.subject | SEROPREVALENCE | |
dc.subject | IRAN | |
dc.subject | SEROEPIDEMIOLOGY | |
dc.subject | TRANSFUSION | |
dc.subject | MAURITANIA | |
dc.subject | PROVINCE | |
dc.title | Epidemiology and Risk Factors of Hepatitis Delta Infection in Turkey | |
dc.type | Article |